SCHEMBL6489154

SCHEMBL6489154

CCOC(=O)CCCOc1cc(C)c2nc(C)n(Cc3ccccc3Cl)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 2/20 0.47
HTT P42858 1/20 0.47
PLA2G2A P14555 3/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYSLTR2 Q9NS75 3/20 0.43
CYSLTR1 Q9Y271 3/20 0.43
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6501772 0.93 PIK3C2B (0.47) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6502915 0.90 SMN1; SMN2 (0.44) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6488906 0.90 MEN1 (0.40) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6492166 0.90 GAA (0.43) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6503536 0.90 MCL1 (0.46) PLA2G2AMCL1PPARGDCTPP1
SCHEMBL6488241 0.89 MCL1 (0.43) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6499832 0.88 PLA2G2A (0.42) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6491512 0.88 MCL1 (0.41) ALDH1A1MAPTHSD17B10PLA2G2ACYSLTR2
SCHEMBL6488675 0.88 PLA2G2A (0.41) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL6487942 0.88 MCL1 (0.42) PLA2G2ACYSLTR2CYSLTR1GAAMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD ALDH1A1 96/4885MAPT 3168/4885KDM4E 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.